Edesa Biotech EDSA
NASDAQ EDSA
$4.00 -0.01 (-0.25%)
As of: Oct 2, 2026 · 12:40 PM EDT

Edesa Biotech (EDSA) Cash from Financing Activities (2013 - 2025)

Updated

Edesa Biotech (EDSA) reported Cash from Financing Activities of $3.36 million for fiscal Q1 2026 (quarter ended Dec 31, 2025), up 62.0% from $2.07 million a year earlier.

Analysis

Edesa Biotech (EDSA) Cash from Financing Activities (2013 - 2025) Analysis & Trends

Over the twelve months ended Dec 31, 2025, Edesa Biotech's Cash from Financing Activities came in at $18.31 million, up 676.8% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $17.03 million.

  • Cash from Financing Activities has a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
  • By fiscal year, Cash from Financing Activities came in at $592,031 in FY2024 (-87.7%), $4.83 million in FY2023 (-58.5%), $11.63 million in FY2022 (-18.0%) and $14.17 million in FY2021 (+99.8%).
  • Five-year quarterly Cash from Financing Activities spans a low of -$31,435 in fiscal Q4 2024 and a high of $14.77 million in fiscal Q2 2025.
  • Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 120.4%.
  • The high point for year-over-year Cash from Financing Activities in five years was fiscal Q1 2025 (growth of 577.5%); the low point was fiscal Q4 2021 (a decline of 93.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Edesa Biotech 40.56 Mn 40.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.36 Mn
Sep 30, 2025 186,483.00
Mar 31, 2025 14.77 Mn
Dec 31, 2024 2.07 Mn
Sep 30, 2024 -31,435.00
Jun 30, 2024 106,025.00
Mar 31, 2024 211,699.00
Dec 31, 2023 305,742.00
Sep 30, 2023 412,465.00
Jun 30, 2023 741,231.00
Mar 31, 2023 764,640.00
Dec 31, 2022 2.91 Mn
Sep 30, 2022 -286.00
Mar 31, 2022 10.40 Mn
Dec 31, 2021 1.23 Mn
Sep 30, 2021 221,037.00
Jun 30, 2021 15,906.00
Mar 31, 2021 11.94 Mn
Dec 31, 2020 1.99 Mn
Sep 30, 2020 3.23 Mn
API Access

Edesa Biotech Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=EDSA&period=max&api_key=YOUR_API_KEY